DJIA 17,130.46 -1.51 -0.01%
NASDAQ 4,551.26 -1.50 -0.03%
S&P 500 1,997.37 -1.61 -0.08%
market minute promo

159.87 4.00 (2.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SLXP $159.87 2.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $159.03
Previous Close $155.87
Daily Range $158.32 - $164.80
52-Week Range $65.38 - $164.80
Market Cap $10.2B
P/E Ratio 181.24
Dividend (Yield) $0.00 (0.0%)
Volume 1,656,465
Average Daily Volume 1,530,355
Current FY EPS $2.10

Sector

Healthcare

Industry

Drugs

Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website: http://www.salix.com/

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Today's Momo Momentum Stock To Watch: Salix Pharmaceuticals (SLXP)

Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today

Sector Update: Health-Care Shares Mixed Pre-Market

Sector Update: Health Care

Technical cross currents surface ahead of the Fed

Strong On High Volume: Salix Pharmaceuticals (SLXP)

Sector Update: Health-Care Shares Flat Pre-Market

Sector Update: Health-Care Shares Flat Pre-Market

Sector Update: Health Care

UCERIS 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis

UCERIS 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis Granted Tentative Approval By FDA

Interesting SLXP Put And Call Options For January 2017

See More SLXP News...

SLXP's Top Competitors

SLXP $159.87 (2.57%)
Current stock: SLXP
JNJ $106.01 (0.12%)
Current stock: JNJ
NVS $95.16 (0.83%)
Current stock: NVS
RHHBY $37.60 (0.32%)
Current stock: RHHBY